文献速递内脏/肾动脉与血管畸形

内脏动脉瘤腔内与开放手术的治疗趋势及结局

Trends and outcomes in endovascular and open surgical treatment of visceral aneurysms.
PubMed 文献 · J Vasc Surg · 2017-05-11

基于2003至2013年美国全国住院患者样本数据库,共9260例内脏动脉瘤干预(腔内5166例,开放4094例)。腔内修复从5.3增至24.7例/千万人口(P<.001),2008年超过开放;P<.001)增加相关,且住院时间更短(6.5 vs 8.7天;P<.001)。

要点

  • 腔内修复VAA从5.3增至24.7例/千万人口,2008年超过开放手术。
  • 腔内患者合并症更重、非择期比例更高(28.9% vs 59.8%)。
  • 多因素校正后开放手术与死亡率(OR 1.70)和并发症(OR 1.78)增加相关。

核心结论

  • 腔内VAA修复呈增长趋势,尽管患者合并症更重且非择期入院更多,腔内治疗与死亡率和并发症降低及住院时间缩短相关。

研究设计与样本

  • 基于2003至2013年AHRQ国家住院患者样本数据库的回顾性人群研究,纳入9260例VAA干预(腔内5166例,开放4094例),排除肾动脉或腹主动脉/胸腹主动脉疾病患者。

主要发现

  • 腔内修复从5.3增至24.7例/千万美国人口(P<.001),开放修复从14.3降至9.2例/千万(P<.001),腔内于2008年超过开放。
  • 腔内患者更多在城市教学医院治疗(77.1% vs 61.8%;P<.0001),合并肾衰竭(7.6% vs 4.9%;P=.02)、肝病(11.3% vs 6.6%;P<.001)、酒精滥用(13.1% vs 3.6%;P<.001)、慢性失血性贫血(4.5% vs 1.6%;P<.001)、转移性癌症(2.7% vs 0.8%;P=.003)、无转移实体瘤(3.6% vs 2.0%;P<.037)和体重减轻(9.8% vs 5.2%;P<.001)比例更高,择期入院比例更低(28.9% vs 59.8%;P<.0001)。
  • 两组院内死亡率(4.1% vs 4.5%;P=.618)和总并发症率(37.8% vs 38.8%;P=.688)相似,但腔内患者肺部并发症更少(10.6% vs 19.7%;P<.001),住院时间更短(6.5 vs 8.7天;P<.001)。

临床怎么用

  • 对于内脏动脉瘤,腔内修复可作为优先考虑,尤其适用于合并症多、非择期入院患者,以降低死亡率和并发症并缩短住院时间。

局限性

  • 研究为回顾性数据库分析,可能存在选择偏倚和未测量混杂因素。
  • 仅评估院内结局,缺乏长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Visceral artery aneurysms (VAAs) are rare but often repaired because of dire consequences of rupture. This is a population-based evaluation of chronologic trends in management, risk factors, and outcomes of endovascular and open therapy. METHODS: The 2003 to 2013 Agency for Healthcare Research and Quality (AHRQ) National Inpatient Sample (NIS) database was reviewed. Cases with primary diagnosis of VAA and undergoing endovascular or open repair were identified. Patients with renal artery or abdominal or thoracoabdominal aortic disease were excluded. Case numbers of respective techniques were charted over time. Baseline characteristics and in-hospital outcomes were compared for endovascular and open groups using χ2 test, Fisher exact test, or t-test. Predictors of mortality and complications were evaluated with multivariate logistic regression. RESULTS: There were 9260 interventions for VAAs from 2003 to 2013, including 5166 endovascular and 4094 open. Endovascular repairs increased from 5.3 to 24.7 per 10 million U.S. population (P < .001), surpassing open repairs in 2008, which decreased from 14.3 to 9.2 per 10 million (P < .001). Endovascular patients were more likely to have been treated at urban teaching hospitals (77.1% vs 61.8%; P < .0001); to have higher proportions of renal failure (7.6% vs 4.9%; P = .02), liver disease (11.3% vs 6.6%; P < .001), alcohol abuse (13.1% vs 3.6%; P < .001), chronic blood loss anemia (4.5% vs 1.6%; P < .001), metastatic cancer (2.7% vs 0.8%; P = .003), solid tumor without metastases (3.6% vs 2.0%; P < .037), and weight loss (9.8% vs 5.2%; P < .001); and less likely to have had elective admission (28.9% vs 59.8%; P < .0001). In-hospital mortality (4.1% vs 4.5%; P = .618) and overall complication rates (37.8% vs 38.8%; P = .688) were similar between groups; however, pulmonary complications were decreased for endovascular patients (10.6% vs 19.7%; P < .001). Endovascular patients had shorter hospital stays (6.5 vs 8.7 days; P < .001). Multivariate adjustment for mortality predictors, including coagulopathy (odds ratio [OR], 4.34; confidence interval [CI], 2.56-7.35; P < .001), liver disease (OR, 2.25; CI, 1.25-4.07; P = .01), fluid and electrolyte disorders (OR, 2.84; CI, 1.73-4.66; P < .001), and solid tumor without metastases (OR, 2.81; CI, 1.10-7.18; P = .03), showed that open treatment was associated with increased mortality (OR, 1.70; CI, 1.03-2.81; P = .04). Analysis of overall complications revealed that open treatment was again associated with increased complications (OR, 1.78; CI, 1.43-2.21; P < .001). CONCLUSIONS: Endovascular VAA repairs are increasing. Despite patients' having worse comorbidities and more nonelective admissions, endovascular therapy appears to be associated with decreased mortality and complications and shorter hospital stays.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Chin JA, Heib A, Ochoa Chaar CI, et al. Trends and outcomes in endovascular and open surgical treatment of visceral aneurysms. J Vasc Surg. 2017. PMID: 28502540. doi:10.1016/j.jvs.2017.02.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。